Biodesix (BDSX) Other Non Operating Income (2019 - 2026)

Biodesix has reported Other Non Operating Income for 8 years, with the latest figure at $385000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 292.86% year-over-year to $385000.0; the trailing twelve-month figure through Mar 2026 stood at $891000.0 (up 119.46% YoY), and the FY2025 full-year result was $604000.0, up 727.4% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $385000.0, up from $46000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $409000.0 in Q3 2025, with the low at -$4.2 million in Q2 2022.
• Historically, Other Non Operating Income has averaged -$378588.2 across 5 years, with a median of $2000.0 in 2023.
• The largest YoY upside for Other Non Operating Income was 18600.0% in 2024 against a maximum downside of 38800.0% in 2024.
• Biodesix's Other Non Operating Income stood at -$400000.0 in 2022, then jumped by 100.5% to $2000.0 in 2023, then jumped by 15950.0% to $321000.0 in 2024, then plunged by 85.67% to $46000.0 in 2025, then surged by 736.96% to $385000.0 in 2026.
• The last three Other Non Operating Income figures came in at $385000.0 (Q1 2026), $46000.0 (Q4 2025), and $409000.0 (Q3 2025), per Business Quant data.